Cargando…
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
The success of cellular immunotherapies against cancer requires the generation of activated CD4(+) and CD8(+) T-cells. The type of T-cell response generated (e.g., Th1 or Th2) will determine the efficacy of the therapy, and it is generally assumed that a type-1 response is needed for optimal cancer...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494209/ https://www.ncbi.nlm.nih.gov/pubmed/26344346 http://dx.doi.org/10.3390/vaccines1040527 |